1. Zejula (niraparib)
    Zejula (niraparib)
    by Tesaro UK Limited
    for Gynaecological Cancer
  2. Tecentriq (atezolizumab)
    Tecentriq (atezolizumab)
    by Roche Registration Limited
    for Urothelial Carcinoma, Lung Cancer
  3. Tagrisso (osimertinib)
    Tagrisso (osimertinib)
    by AstraZeneca AB
    for Lung Cancer
  4. Rydapt (midostaurin)
    Rydapt (midostaurin)
    by Novartis Europharm Limited
    for Leukemia
  5. Rubraca (rucaparib)
    Rubraca (rucaparib)
    by Clovis Oncology, Inc.
    for Gynaecological Cancer
  6. Portrazza (necitumumab)
    Portrazza (necitumumab)
    by Eli Lilly Nederland B.V.
    for Lung Cancer
  7. Perjeta (pertuzumab)
    Perjeta (pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
  8. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
  9. Onivyde (irinotecan hydrochloride trihydrate)
    Onivyde (irinotecan hydrochloride trihydrate)
    by Baxalta Innovations GmbH
    for Pancreatic Cancer
View as Grid List

Items 1-9 of 32

per page
Set Descending Direction